161 related articles for article (PubMed ID: 20472438)
1. The scope of thallium nitrate oxidative cyclization of chalcones; synthesis and evaluation of isoflavone and aurone analogs for their inhibitory activity against interleukin-5.
Thanigaimalai P; Yang HM; Sharma VK; Kim Y; Jung SH
Bioorg Med Chem; 2010 Jun; 18(12):4441-5. PubMed ID: 20472438
[TBL] [Abstract][Full Text] [Related]
2. Structural requirement of chalcones for the inhibitory activity of interleukin-5.
Yang HM; Shin HR; Cho SH; Bang SC; Song GY; Ju JH; Kim MK; Lee SH; Ryu JC; Kim Y; Jung SH
Bioorg Med Chem; 2007 Jan; 15(1):104-11. PubMed ID: 17064909
[TBL] [Abstract][Full Text] [Related]
3. Influence of the skeleton on the cytotoxicity of flavonoids.
Lewin G; Aubert G; Thoret S; Dubois J; Cresteil T
Bioorg Med Chem; 2012 Feb; 20(3):1231-9. PubMed ID: 22257529
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel chromone analogs for their inhibitory activity against interleukin-5.
Thanigaimalai P; Le Hoang TA; Lee KC; Sharma VK; Bang SC; Yun JH; Roh E; Kim Y; Jung SH
Eur J Med Chem; 2010 Jun; 45(6):2531-6. PubMed ID: 20226573
[TBL] [Abstract][Full Text] [Related]
5. Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
Detsi A; Majdalani M; Kontogiorgis CA; Hadjipavlou-Litina D; Kefalas P
Bioorg Med Chem; 2009 Dec; 17(23):8073-85. PubMed ID: 19853459
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibitory properties of ferrocene-substituted chalcones and aurones on bacterial and human cell cultures.
Tiwari KN; Monserrat JP; Hequet A; Ganem-Elbaz C; Cresteil T; Jaouen G; Vessières A; Hillard EA; Jolivalt C
Dalton Trans; 2012 Jun; 41(21):6451-7. PubMed ID: 22240736
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of isoflavones substituted in ring B by the oxidative rearrangement of 2'-hydroxychalcones with thallium (III) nitrate.
Lévai A; Balogh L
Pharmazie; 1975 Nov; 30(11):747. PubMed ID: 1219781
[No Abstract] [Full Text] [Related]
8. Identification of novel chromenone derivatives as interleukin-5 inhibitors.
Venkateswararao E; Kim MS; Sharma VK; Lee KC; Subramanian S; Roh E; Kim Y; Jung SH
Eur J Med Chem; 2013 Jan; 59():31-8. PubMed ID: 23202848
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative evaluation of amide-containing flavone and isoflavone derivatives.
Chen IL; Chen JY; Shieh PC; Chen JJ; Lee CH; Juang SH; Wang TC
Bioorg Med Chem; 2008 Aug; 16(16):7639-45. PubMed ID: 18662883
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel chromenone derivatives as interleukin-5 inhibitors.
Venkateswararao E; Sharma VK; Lee KC; Roh E; Kim Y; Jung SH
Bioorg Med Chem; 2013 May; 21(9):2543-50. PubMed ID: 23523388
[TBL] [Abstract][Full Text] [Related]
11. Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes.
Okombi S; Rival D; Bonnet S; Mariotte AM; Perrier E; Boumendjel A
J Med Chem; 2006 Jan; 49(1):329-33. PubMed ID: 16392817
[TBL] [Abstract][Full Text] [Related]
12. The role of alkoxy group on the A ring of isoflavones in the inhibition of interleukin-5.
Yang HM; Shin HR; Bang SC; Lee KC; Hoang le TA; Lee IJ; Kim Y; Jung SH
Arch Pharm Res; 2007 Aug; 30(8):950-4. PubMed ID: 17879747
[TBL] [Abstract][Full Text] [Related]
13. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
Loa J; Chow P; Zhang K
Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
[TBL] [Abstract][Full Text] [Related]
14. Structure activity relationship studies of anti-inflammatory TMMC derivatives: 4-dimethylamino group on the B ring responsible for lowering the potency.
Jin YL; Jin XY; Jin F; Sohn DH; Kim HS
Arch Pharm Res; 2008 Sep; 31(9):1145-52. PubMed ID: 18806957
[TBL] [Abstract][Full Text] [Related]
15. Novel analogs of N-acylhydroxyethylaminomethyl-4H-chromen-4-one scaffold as IL-5 inhibitors.
Yang HS; Venkateswararao E; Boggu PR; Sharma VK; Kim Y; Jung SH
Bioorg Med Chem; 2017 Aug; 25(16):4330-4338. PubMed ID: 28651915
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agents.
Sivakumar PM; Priya S; Doble M
Chem Biol Drug Des; 2009 Apr; 73(4):403-15. PubMed ID: 19291103
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles.
Abdel-Wahab BF; Abdel-Aziz HA; Ahmed EM
Eur J Med Chem; 2009 Jun; 44(6):2632-5. PubMed ID: 18995932
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones.
Sun H; Li Y; Zhang X; Lei Y; Ding W; Zhao X; Wang H; Song X; Yao Q; Zhang Y; Ma Y; Wang R; Zhu T; Yu P
Bioorg Med Chem Lett; 2015 Oct; 25(20):4567-71. PubMed ID: 26351039
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of aurones against Plasmodium falciparum strains K1 and NF54.
Kayser O; Kiderlen AF; Brun R
Planta Med; 2001 Nov; 67(8):718-21. PubMed ID: 11731912
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel hydroxyalkylaminomethylchromones for their IL-5 inhibitory activity.
Thanigaimalai P; Lee KC; Sharma VK; Yun JH; Kim Y; Jung SH
Bioorg Med Chem; 2010 Jul; 18(13):4625-9. PubMed ID: 20627591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
